Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

Detalles Bibliográficos
Autores principales: Spring, Laura M., Han, Hyo, Liu, Minetta C., Hamilton, Erika, Irie, Hanna, Santa-Maria, Cesar A., Reeves, James, Pan, Peng, Shan, Ming, Tang, Yongqiang, Graham, Julie R., Hazard, Sebastien, Ellisen, Leif W., Isakoff, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499859/
https://www.ncbi.nlm.nih.gov/pubmed/35931884
http://dx.doi.org/10.1038/s43018-022-00430-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499859/
https://www.ncbi.nlm.nih.gov/pubmed/35931884
http://dx.doi.org/10.1038/s43018-022-00430-w

Ejemplares similares